Acotec (6669 HK): Boston Scientific's Partial Offer Open For Tendering

David has highlighted this Insight as a Top Pick
561 Views04 Jan 2023 11:51
Proration will likely be higher than 71.31%. Boston Scientific views Acotec as a vehicle to strengthen its presence in China. There will be investors playing the back-end.  Buy here and on any dips.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 6-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
David Blennerhassett
Pan-Asia Catalysts/Events
Quiddity Advisors
EquitiesEvent-Driven
Price Chart(Sign Up to Access)
analytics-chart
x